AIMS 2025: Emmanuel J Favaloro’s Haemostasis Tour Hits Finale
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Just completed my final session as the Australian Institute of Medical and Clinical Scientists (AIMS) 2025 Travelling Orator, in Adelaide for the South Australian (SA)/Northern Territory (NT) Branch. A well organised and well attended (pre-)Christmas meeting where I spoke on the topic of “Advances in Haemostasis”. This assignment has been an honour for me.
In total, 6 different venues, with 11 presentations, covering all states and territories in Australia (bar Queensland and the ACT). In total, around 500 attendees, both young and not so young.
Hope to be selected again before I hang up my haemostasis hat for good.”
Stay updated with Hemostasis Today.
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention